Related Experiment Video
Updated: Apr 12, 2026
04:06
Author Spotlight: Minimally Invasive Relief for Occipital Neuralgia at the Nuchal Line
Published on: September 13, 2024
4.0K
[Occipital nerve stimulation for refractory chronic migraine]
Pedro E Bermejo1, Cristina V Torres, Rafael G Sola
1Hospital Universitario Puerta de Hierro-Majadahonda, 28035 Majadahonda, Espana.
Revista De Neurologia
|May 26, 2015
Summary
Occipital nerve stimulation (ONS) offers a promising preventive treatment for chronic migraine. This therapy is safe, well-tolerated, and effective in reducing pain for many patients.
Area of Science:
- Neuromodulation
- Neurosurgery
- Pain Management
Background:
- Chronic migraine affects 2% of the population, causing significant disability.
- Refractory chronic migraine lacks effective preventive treatments.
- Occipital nerve stimulation (ONS) is an emerging therapy for this condition.
Purpose of the Study:
- To review ONS mechanisms, clinical studies, and implantation techniques for migraine prevention.
- To evaluate ONS as a treatment for refractory chronic migraine.
- To assess ONS inclusion criteria and efficacy.
Main Methods:
- Non-systematic literature review on ONS for refractory chronic migraine.
- Analysis of clinical studies, implantation techniques, and patient selection.
- Evaluation of safety and tolerability data.
Main Results:
- ONS demonstrates >50% pain reduction in most open-label studies and clinical trials.
- Mechanisms may involve neuromodulation of trigeminal nociceptive pathways.
- ONS is safe and well-tolerated, with common side effects being local.
Conclusions:
- Occipital nerve stimulation is an effective, safe, and well-tolerated preventive treatment for chronic migraine.
- ONS can be a valuable option for patients with medically refractory chronic migraine.
- Further research into ONS mechanisms is warranted.
